Published in Biochemistry on September 27, 2005
Apolipoprotein A-I mimetic peptide helix number and helix linker influence potentially anti-atherogenic properties. J Lipid Res (2008) 1.39
Active protein aggregates induced by terminally attached self-assembling peptide ELK16 in Escherichia coli. Microb Cell Fact (2011) 1.16
Experimental approaches for solution X-ray scattering and fiber diffraction. Curr Opin Struct Biol (2008) 1.16
The fibrillogenic L178H variant of apolipoprotein A-I forms helical fibrils. J Lipid Res (2011) 1.05
The specific amino acid sequence between helices 7 and 8 influences the binding specificity of human apolipoprotein A-I for high density lipoprotein (HDL) subclasses: a potential for HDL preferential generation. J Biol Chem (2008) 0.88
Fusion of an oligopeptide to the N terminus of an alkaline α-amylase from Alkalimonas amylolytica simultaneously improves the enzyme's catalytic efficiency, thermal stability, and resistance to oxidation. Appl Environ Microbiol (2013) 0.86
Relation between molecular shape and the morphology of self-assembling aggregates: a simulation study. Biophys J (2011) 0.82
Elucidation of the Aggregation Pathways of Helix-Turn-Helix Peptides: Stabilization at the Turn Region Is Critical for Fibril Formation. Biochemistry (2015) 0.76
Aggregation of Chameleon Peptides: Implications of α-Helicity in Fibril Formation. J Phys Chem B (2016) 0.75
Fusion of self-assembling amphipathic oligopeptides with cyclodextrin glycosyltransferase improves 2-O-D-glucopyranosyl-L-ascorbic acid synthesis with soluble starch as the glycosyl donor. Appl Environ Microbiol (2014) 0.75
Molecular structure of β-amyloid fibrils in Alzheimer's disease brain tissue. Cell (2013) 4.02
Site specificity of atherosclerosis: site-selective responses to atherosclerotic modulators. Arterioscler Thromb Vasc Biol (2003) 3.35
Supramolecular structure in full-length Alzheimer's beta-amyloid fibrils: evidence for a parallel beta-sheet organization from solid-state nuclear magnetic resonance. Biophys J (2002) 2.78
Relapse or eradication of cancer is predicted by peptide-major histocompatibility complex affinity. Cancer Cell (2013) 2.18
Increasing tumor antigen expression overcomes "ignorance" to solid tumors via crosspresentation by bone marrow-derived stromal cells. Immunity (2002) 2.18
Seeded growth of beta-amyloid fibrils from Alzheimer's brain-derived fibrils produces a distinct fibril structure. Proc Natl Acad Sci U S A (2009) 2.15
Collagen fibril architecture, domain organization, and triple-helical conformation govern its proteolysis. Proc Natl Acad Sci U S A (2008) 2.13
Lymphotoxin beta receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged ApoE-/- mice. J Exp Med (2009) 2.12
Lymphotoxin beta receptor-dependent control of lipid homeostasis. Science (2007) 2.06
The 2.5 Å structure of CD1c in complex with a mycobacterial lipid reveals an open groove ideally suited for diverse antigen presentation. Immunity (2010) 2.02
Abeta40-Lactam(D23/K28) models a conformation highly favorable for nucleation of amyloid. Biochemistry (2005) 1.78
Flanking polyproline sequences inhibit beta-sheet structure in polyglutamine segments by inducing PPII-like helix structure. J Mol Biol (2007) 1.59
Genetic background selectively influences innominate artery atherosclerosis: immune system deficiency as a probe. Arterioscler Thromb Vasc Biol (2003) 1.50
Evidence for novel beta-sheet structures in Iowa mutant beta-amyloid fibrils. Biochemistry (2009) 1.45
Dexamethasone promotes tolerance in vivo by enriching CD11clo CD40lo tolerogenic macrophages. Eur J Immunol (2012) 1.45
Peptide-based inhibitors of amyloid assembly. Methods Enzymol (2006) 1.44
A mutant chaperone converts a wild-type protein into a tumor-specific antigen. Science (2006) 1.44
Increasing the amphiphilicity of an amyloidogenic peptide changes the beta-sheet structure in the fibrils from antiparallel to parallel. Biophys J (2004) 1.41
Structure of substrate-free human insulin-degrading enzyme (IDE) and biophysical analysis of ATP-induced conformational switch of IDE. J Biol Chem (2007) 1.41
Apolipoprotein A-I mimetic peptide helix number and helix linker influence potentially anti-atherogenic properties. J Lipid Res (2008) 1.39
Human oxidation-specific antibodies reduce foam cell formation and atherosclerosis progression. J Am Coll Cardiol (2011) 1.16
An apoA-I mimetic peptide containing a proline residue has greater in vivo HDL binding and anti-inflammatory ability than the 4F peptide. J Lipid Res (2009) 1.16
Lysine-phosphatidylcholine adducts in kringle V impart unique immunological and potential pro-inflammatory properties to human apolipoprotein(a). J Biol Chem (2003) 1.13
Characterization of the natural killer T-cell response in an adoptive transfer model of atherosclerosis. Am J Pathol (2007) 1.09
Serum paraoxonase: effect of the apolipoprotein composition of HDL and the acute phase response. J Lipid Res (2003) 1.09
Glyoxalase 1 increases anxiety by reducing GABAA receptor agonist methylglyoxal. J Clin Invest (2012) 1.06
The Japanese mutant Aβ (ΔE22-Aβ(1-39)) forms fibrils instantaneously, with low-thioflavin T fluorescence: seeding of wild-type Aβ(1-40) into atypical fibrils by ΔE22-Aβ(1-39). Biochemistry (2011) 1.05
Probing the role of backbone hydrogen bonding in beta-amyloid fibrils with inhibitor peptides containing ester bonds at alternate positions. Biochemistry (2003) 1.00
Antiatherosclerotic effects of a novel synthetic tissue-selective steroidal liver X receptor agonist in low-density lipoprotein receptor-deficient mice. J Pharmacol Exp Ther (2008) 0.99
4F Peptide reduces nascent atherosclerosis and induces natural antibody production in apolipoprotein E-null mice. FASEB J (2010) 0.99
Influence of apoA-I and apoE on the formation of serum amyloid A-containing lipoproteins in vivo and in vitro. J Lipid Res (2003) 0.99
Self-assembly of HEK cell-secreted ApoE particles resembles ApoE enrichment of lipoproteins as a ligand for the LDL receptor-related protein. Biochemistry (2006) 0.99
Both apolipoprotein E and immune deficiency exacerbate neointimal hyperplasia after vascular injury in mice. Arterioscler Thromb Vasc Biol (2002) 0.98
Engineering mouse apolipoprotein A-I into a monomeric, active protein useful for structural determination. Biochemistry (2005) 0.97
VLDL best predicts aortic root atherosclerosis in LDL receptor deficient mice. J Lipid Res (2008) 0.97
Vitamin D receptor signaling inhibits atherosclerosis in mice. Mol Endocrinol (2012) 0.97
X-ray diffraction study of nanocrystalline and amorphous structure within major and minor ampullate dragline spider silks. Soft Matter (2012) 0.96
Differential anti-atherosclerotic effects in the innominate artery and aortic sinus by the liver X receptor agonist T0901317. Atherosclerosis (2008) 0.95
Mechanism of cis-inhibition of polyQ fibrillation by polyP: PPII oligomers and the hydrophobic effect. Biophys J (2009) 0.95
In situ D-periodic molecular structure of type II collagen. J Biol Chem (2010) 0.90
Non-enzymatic decomposition of collagen fibers by a biglycan antibody and a plausible mechanism for rheumatoid arthritis. PLoS One (2012) 0.90
Site-specific effects of peptide lipidation on beta-amyloid aggregation and cytotoxicity. J Biol Chem (2007) 0.89
Strong synergy between mutant ras and HPV16 E6/E7 in the development of primary tumors. Oncogene (2004) 0.89
Apolipoprotein E structural requirements for the formation of SDS-stable complexes with beta-amyloid-(1-40): the role of salt bridges. Biochem J (2002) 0.89
The specific amino acid sequence between helices 7 and 8 influences the binding specificity of human apolipoprotein A-I for high density lipoprotein (HDL) subclasses: a potential for HDL preferential generation. J Biol Chem (2008) 0.88
Protein folding: sticky N17 speeds huntingtin pile-up. Nat Chem Biol (2010) 0.86
Arginine/arginase NO NO NO. Arterioscler Thromb Vasc Biol (2006) 0.85
Spatial separation of beta-sheet domains of beta-amyloid: disruption of each beta-sheet by N-methyl amino acids. Biochemistry (2006) 0.84
Preferential interactions between ApoE-containing lipoproteins and Aβ revealed by a detection method that combines size exclusion chromatography with non-reducing gel-shift. Biochim Biophys Acta (2011) 0.84
Site-specific influence of polyunsaturated fatty acids on atherosclerosis in immune incompetent LDL receptor deficient mice. Atherosclerosis (2005) 0.84
Structural heterogeneity in transmembrane amyloid precursor protein homodimer is a consequence of environmental selection. J Am Chem Soc (2014) 0.84
Differential effects of activation of liver X receptor on plasma lipid homeostasis in wild-type and lipoprotein clearance-deficient mice. Atherosclerosis (2009) 0.84
Apolipoprotein A-I alpha -helices 7 and 8 modulate high density lipoprotein subclass distribution. J Biol Chem (2001) 0.84
Transmembrane fragment structures of amyloid precursor protein depend on membrane surface curvature. J Am Chem Soc (2014) 0.84
Increased levels of invariant natural killer T lymphocytes worsen metabolic abnormalities and atherosclerosis in obese mice. J Lipid Res (2013) 0.83
Apolipoprotein A-I protection against atherosclerosis is dependent on genetic background. Arterioscler Thromb Vasc Biol (2013) 0.83
Import of yeast mitochondrial transcription factor (Mtf1p) via a nonconventional pathway. J Biol Chem (2002) 0.83
Autoantibodies to OxLDL fail to alter the clearance of injected OxLDL in apolipoprotein E-deficient mice. J Lipid Res (2004) 0.83
Dinosaur peptides suggest mechanisms of protein survival. PLoS One (2011) 0.83
Requirement of different mitochondrial targeting sequences of the yeast mitochondrial transcription factor Mtf1p when synthesized in alternative translation systems. Biochem J (2004) 0.82
ApoE derived from adipose tissue does not suppress atherosclerosis or correct hyperlipidemia in apoE knockout mice. J Lipid Res (2012) 0.82
γδ T cell receptors recognize the non-classical major histocompatibility complex (MHC) molecule T22 via conserved anchor residues in a MHC peptide-like fashion. J Biol Chem (2012) 0.82
Chaperone-like N-methyl peptide inhibitors of polyglutamine aggregation. Biochemistry (2010) 0.82
Thematic review series: the immune system and atherogenesis. Bridging the innate and adaptive immune systems. J Lipid Res (2005) 0.81
High-resolution structure of a self-assembly-competent form of a hydrophobic peptide captured in a soluble beta-sheet scaffold. J Mol Biol (2008) 0.81
A novel potent synthetic steroidal liver X receptor agonist lowers plasma cholesterol and triglycerides and reduces atherosclerosis in LDLR(-/-) mice. Br J Pharmacol (2011) 0.80
Naturally occurring variant of mouse apolipoprotein A-I alters the lipid and HDL association properties of the protein. J Lipid Res (2012) 0.80
Lipoproteins produced by ApoE-/- astrocytes infected with adenovirus expressing human ApoE. J Neurochem (2003) 0.80
LIGHT/TNFSR14 can regulate hepatic lipase expression by hepatocytes independent of T cells and Kupffer cells. PLoS One (2013) 0.79
High-density lipoprotein function in regulating insulin secretion: possible relevance to metabolic syndrome. Arterioscler Thromb Vasc Biol (2010) 0.78
Novel semisynthetic method for generating full length beta-amyloid peptides. Biopolymers (2010) 0.77
Chemical colloids versus biological colloids: a comparative study for the elucidation of the mechanism of protein fiber formation. Biochemistry (2005) 0.77
Differing rates of cholesterol absorption among inbred mouse strains yield differing levels of HDL-cholesterol. J Lipid Res (2013) 0.76
Do natural killer cells participate in a killer vascular disease? Arterioscler Thromb Vasc Biol (2002) 0.76
Elucidation of the Aggregation Pathways of Helix-Turn-Helix Peptides: Stabilization at the Turn Region Is Critical for Fibril Formation. Biochemistry (2015) 0.76
Murine atherosclerosis. Part III. Curr Drug Targets (2008) 0.75
Versatile cyclic templates for assembly of axially oriented ligands. Bioconjug Chem (2009) 0.75
The ABC transporters and the thickening cholesterol plot. Curr Opin Lipidol (2011) 0.75
Atherosclerosis: beyond cholesterol. Curr Opin Lipidol (2011) 0.75
Encapsulation and NMR on an aggregating peptide before fibrillogenesis. J Am Chem Soc (2006) 0.75
ABC transporters: lipid transport and inflammation. Curr Opin Lipidol (2010) 0.75